It is well established that detecting and diagnosing cancer earlier significantly improves patient outcomes. Therefore, the identification of cancer biomarkers […]
An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]
Liquid biopsy is rapidly transforming how cancer is detected, monitored, and treated. While major progress has been made in identifying tumour-derived signals in […]
Liquid biopsy is moving rapidly from a promising research tool into an increasingly important component of oncology practice. Its applications across early […]
What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of […]
The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […]
Our recent webinar series, ‘Unlocking Precision Oncology’s Full Potential through Next-Gen Molecular Analysis’, showcased cutting-edge advances in diagnostics, molecular profiling […]
